Literature DB >> 11294654

NMR solution studies of hamster galectin-3 and electron microscopic visualization of surface-adsorbed complexes: evidence for interactions between the N- and C-terminal domains.

B Birdsall1, J Feeney, I D Burdett, S Bawumia, E A Barboni, R C Hughes.   

Abstract

Galectin-3, a beta-galactoside binding protein, contains a C-terminal carbohydrate recognition domain (CRD) and an N-terminal domain that includes several repeats of a proline-tyrosine-glycine-rich motif. Earlier work based on a crystal structure of human galectin-3 CRD, and modeling and mutagenesis studies of the closely homologous hamster galectin-3, suggested that N-terminal tail residues immediately preceding the CRD might interfere with the canonical subunit interaction site of dimeric galectin-1 and -2, explaining the monomeric status of galectin-3 in solution. Here we describe high-resolution NMR studies of hamster galectin-3 (residues 1--245) and several of its fragments. The results indicate that the recombinant N-terminal fragment Delta 126--245 (residues 1--125) is an unfolded, extended structure. However, in the intact galectin-3 and fragment Delta 1--93 (residues 94--245), N-terminal domain residues lying between positions 94 and 113 have significantly reduced mobility values compared with those expected for bulk N-terminal tail residues, consistent with an interaction of this segment with the CRD domain. In contrast to the monomeric status of galectin-3 (and fragment Delta 1--93) in solution, electron microscopy of negatively stained and rotary shadowed samples of hamster galectin-3 as well as the CRD fragment Delta 1--103 (residues 104--245) show the presence of a significant proportion (up to 30%) of oligomers. Similar imaging of the N-terminal tail fragment Delta 126--245 reveals the presence of fibrils formed by intermolecular interactions between extended polypeptide subunits. Oligomerization of substratum-adsorbed galectin-3, through N- and C-terminal domain interactions, could be relevant to the positive cooperativity observed in binding of the lectin to immobilized multiglycosylated proteins such as laminin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294654     DOI: 10.1021/bi002907f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

2.  Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.

Authors:  Hans Ippel; Michelle C Miller; Sabine Vértesy; Yi Zheng; F Javier Cañada; Dennis Suylen; Kimiko Umemoto; Cecilia Romanò; Tilman Hackeng; Guihua Tai; Hakon Leffler; Jürgen Kopitz; Sabine André; Dieter Kübler; Jesús Jiménez-Barbero; Stefan Oscarson; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

3.  Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3.

Authors:  Richard M Gray; Michael J Davis; Katherine M Ruby; Patricia G Voss; Ronald J Patterson; John L Wang
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

Review 4.  Galectin-3 in cardiac remodeling and heart failure.

Authors:  Rudolf A de Boer; Lili Yu; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2010-03

5.  The intrinsically disordered N-terminal domain of galectin-3 dynamically mediates multisite self-association of the protein through fuzzy interactions.

Authors:  Yu-Hao Lin; De-Chen Qiu; Wen-Han Chang; Yi-Qi Yeh; U-Ser Jeng; Fu-Tong Liu; Jie-Rong Huang
Journal:  J Biol Chem       Date:  2017-09-11       Impact factor: 5.157

6.  Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.

Authors:  Michelle C Miller; Hans Ippel; Dennis Suylen; Anatole A Klyosov; Peter G Traber; Tilman Hackeng; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-01       Impact factor: 4.313

7.  Ligand induced galectin-3 protein self-association.

Authors:  Adriana Lepur; Emma Salomonsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 8.  Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments.

Authors:  Ana Carolina Ferreira Cardoso; Luciana Nogueira de Sousa Andrade; Silvina Odete Bustos; Roger Chammas
Journal:  Front Oncol       Date:  2016-05-23       Impact factor: 6.244

9.  The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis.

Authors:  Jonathas Xavier Pereira; Maria Carolina Braga Azeredo; Felipe Sá Martins; Roger Chammas; Felipe Leite Oliveira; Sofia Nascimento Santos; Emerson Soares Bernardes; Márcia Cury El-Cheikh
Journal:  BMC Cancer       Date:  2016-08-15       Impact factor: 4.430

Review 10.  Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Jennifer E Ho; Fu-Tong Liu; Rudolf A de Boer
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.